DENTSPLY SIRONA Inc

DENTSPLY SIRONA Inc(XRAY)股票分析

$11.290

+0.557 (+4.93%)收盘时

Loading chart…
High
11.550
Open
10.890
VWAP
11.22
Vol
4.61M
Mkt Cap
5.25B
Low
10.830
Amount
51.71M
EV/EBITDA, TTM
6.16

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.

AI analysis of DENTSPLY SIRONA Inc (XRAY)

hold

DENTSPLY SIRONA Inc (XRAY) is currently priced at $11.12, with a forward P/E ratio of 7.29, indicating potential value. However, the RSI is at 43.81, suggesting the stock is neither overbought nor oversold, and the 20-day change is down 16.83%, indicating recent weakness. The main risk is the company's ongoing revenue decline, with Q2 2026 revenues down 4.1% year-over-year, which could impact future performance.

Analyst Ratings (13)

+15.50% upside
Buy
8 Buy
4 Hold
1 Sell
Current: 11.29
最低
12.00
平均
13.04
最高
17.00

Barclays

2026-08-24

目标价

$11

Underweight

Barrington

2026-08-10

目标价

$15

Outperform

BMO Capital

2026-08-07

目标价

$13

Market Perform

Piper Sandler

2026-07-29

目标价

$14

Neutral

BMO Capital

2026-07-08

目标价

$12

Market Perform

估值指标

The current forward P/E ratio for DENTSPLY SIRONA Inc (XRAY) is 7.45, compared to its 5-year average forward P/E of 14.09.

Forward P/E

Undervalued
5Y Average P/E
14.09
Current P/E
7.45
高估
19.55
低估
8.64

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
5.24
Current EV/EBITDA
6.16
高估
31.66
低估
-21.17

Forward P/S

Undervalued
5Y Average P/S
1.55
Current P/S
0.59
高估
2.27
低估
0.83

Alphio AI Price Scenarios for XRAY

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%XRAY

$17.73

情景价格

B

Base

Base · 50%XRAY

$16.62

情景价格

B

Bear

Bear · 25%XRAY

$14.22

情景价格

Whales holding XRAY

A

Armistice Capital LLC

+ HoldingXRAY

+16.99%

3M Return

I

Invenomic Capital Management LP

+ HoldingXRAY

+16.43%

3M Return

A

Ariel Investments, LLC

+ HoldingXRAY

+0.45%

3M Return

P

Paradigm Capital Management, Inc.

+ HoldingXRAY

-15.54%

3M Return

事件时间线

2026-08-06 (ET)

16:30:00

Company Maintains FY26 Revenue Outlook of $3.5B-$3.6B

2026-07-28 (ET)

09:30:00

Dentsply Sirona Expands Partnership with Medline Sinclair

2026-06-11 (ET)

09:30:00

Dentsply Sirona Appoints John Fortson as CFO

2026-05-05 (ET)

16:20:00

Dentsply Sirona Reports Q1 Revenue of $880M

16:20:00

Company Maintains FY26 Revenue Outlook of $3.5B-$3.6B

资讯

XRAY FAQ — answered by Alphio AI

DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).

DENTSPLY SIRONA Inc (XRAY) is currently priced at $11.12, with a forward P/E ratio of 7.29, indicating potential value. However, the RSI is at 43.81, suggesting the stock is neither overbought nor oversold, and the 20-day change is down 16.83%, indicating recent weakness. The main risk is the company's ongoing revenue decline, with Q2 2026 revenues down 4.1% year-over-year, which could impact future performance.

13 analysts cover XRAY: 8 rate it Buy, 4 Hold and 1 Sell. The average price target is 13.04.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始